Genomas Lands $1.4M SBIR Grant | GenomeWeb

NEW YORK (GenomeWeb News) – Genomas has won a $1.4 million grant from the National Institutes of Health to develop pharmacogenomic technology that will help doctors predict drug efficacy and side-effect risk for neuropsychiatric disease patients.

The company plans to use the Small Business Innovation Research grant to continue developing its PhyzioType Systems, which use genetic polymorphisms found through array genotyping and an algorithm to help doctors develop personalized drug prescriptions for antidepressants and antipsychotics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.